VPG Medical, Inc. has announced the start of a trial study on the company’s HealthKam.
A participant in the second Luminate NY accelerator, VPG is the developer of a software that can effectively track heart conditions using a phone or tablet camera. According to founder Jean-Phillippe Couderc, VPG’s HealthKam can function in the background as a patient uses their device, tracking subtle changes in skin color based on heart beats. That, in turn, can serve as an indicator of various heart conditions. VPG was formed from technology developed at the University of Rochester and RIT.
Over time, data gathered can serve as critical information for diagnosing and treating conditions.
“What is critically important about the HealthKam technology is that it requires no effort or change of routine on the part of patients,” Couderc said, in a statement. “Using smart devices has become a prevalent part of daily life, and the HealthKam technology taps into this widespread behavior to help in the treatment of heart failure patients and those suffering from other chronic diseases.”
The study will be carried out in collaboration with Rochester’s Accountable Health Partners. VPG’s technology is also currently being tested on atrial fibrillation patients, through a $1.9 million grant from the National Institutes of Health.